What's The Big Deal About US Biosimilar Approval?
The U.S. Food and Drug Administration awarded its second-ever approval of a biosimilar to Inflectra on April 5, 2016. Developed by Celltrion Inc. and licensed to Pfizer Inc., Inflectra (infliximab-dyyb) is...To view the full article, register now.
Already a subscriber? Click here to view full article